Cynvec
Cynvec is an innovative biotechnology company specializing in developing viral immunotherapies, particularly using Sindbis oncolytic viral vectors to treat cancer. Their proprietary experimental therapy targets tumors by harnessing the immune system, offering a novel approach to cancer treatment that can be administered via injection and effectively distributed throughout the body.
Industries
Nr. of Employees
small (1-50)
Cynvec
New York, New York, United States, North America
Products
Sindbis vector candidate for systemic cancer immunotherapy (ovarian cancer focus)
An experimental Sindbis-based oncolytic viral vector platform paired with tumor-associated antigens to elicit systemic anti-tumor immune responses; intended for development against late-stage epithelial ovarian cancer (preclinical stage).
Sindbis vector candidate for systemic cancer immunotherapy (ovarian cancer focus)
An experimental Sindbis-based oncolytic viral vector platform paired with tumor-associated antigens to elicit systemic anti-tumor immune responses; intended for development against late-stage epithelial ovarian cancer (preclinical stage).
Services
In-house preclinical R&D activities to design, evaluate, and optimize Sindbis-based viral vectors and antigen pairings for oncology indications.
Execution of rodent (rat/mouse) tumor studies to assess tumor reduction, recurrence prevention, and immune memory following vector administration.
In-house preclinical R&D activities to design, evaluate, and optimize Sindbis-based viral vectors and antigen pairings for oncology indications.
Execution of rodent (rat/mouse) tumor studies to assess tumor reduction, recurrence prevention, and immune memory following vector administration.
Expertise Areas
- Viral immunotherapy development
- Oncolytic vector engineering
- Tumor microenvironment modulation
- Tumor-associated antigen immunotherapy
Key Technologies
- Sindbis-based oncolytic vectors
- Tumor-associated antigen targeting (NY-ESO-1)
- LAMR (laminin receptor)-mediated tumor targeting
- Intravenous and intraperitoneal systemic delivery